Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Caddy

Accept: A Phase Ib/Ii Combination of Acalabrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop) for Patients With Diffuse Large B-Cell Lymphoma (Dlbcl)

Hematological Oncology

English

Related publications

CD5-positive Diffuse Large B-Cell Lymphoma Showing Prominent Intra-Sinusoidal Infiltration in the Bone Marrow, Successfully Treated With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone in Combination With Rituximab

Tenri Medical Bulletin

2013

English

A Phase Ii Study of Lenalidomide and Rituximab (R²) Combination in Patients With High-Risk Refractory/Relapsed Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

British Journal of Haematology

Hematology

2016

English

A Phase II Study of Ibrutinib in Combination With Rituximab-Cyclophosphamide-Doxorubicin Hydrochloride-Vincristine Sulfate-Prednisone Therapy in Epstein-Barr Virus-Positive, Diffuse Large B Cell Lymphoma (54179060LYM2003: IVORY Study): Results of the Final Analysis

English

Decitabine Plus R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma: Interim Results of a Phase I/Ii Study

Hematological Oncology

English

Gene Mutations and Copy Number Alterations (Cna) Predict for Early Failure in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Treated With R-Chop

Hematological Oncology

English

Lenalidomide and Obinutuzumab With Chop for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I/Ii Results

Hematological Oncology

English

The Elevation of Cardio-Ankle Vascular Index in a Patient With Malignant Lymphoma Treated With a Combination Therapy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone

Journal of Clinical Medicine Research

2017

English

Fourteen-Day Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop-14): Use It Right or Do Not Use It at All

Leukemia and Lymphoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Caddy

Accept: A Phase Ib/Ii Combination of Acalabrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop) for Patients With Diffuse Large B-Cell Lymphoma (Dlbcl)

Related publications

CD5-positive Diffuse Large B-Cell Lymphoma Showing Prominent Intra-Sinusoidal Infiltration in the Bone Marrow, Successfully Treated With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone in Combination With Rituximab

A Phase Ii Study of Lenalidomide and Rituximab (R²) Combination in Patients With High-Risk Refractory/Relapsed Diffuse Large B-Cell Lymphoma

A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

A Phase II Study of Ibrutinib in Combination With Rituximab-Cyclophosphamide-Doxorubicin Hydrochloride-Vincristine Sulfate-Prednisone Therapy in Epstein-Barr Virus-Positive, Diffuse Large B Cell Lymphoma (54179060LYM2003: IVORY Study): Results of the Final Analysis

Decitabine Plus R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma: Interim Results of a Phase I/Ii Study

Gene Mutations and Copy Number Alterations (Cna) Predict for Early Failure in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Treated With R-Chop

Lenalidomide and Obinutuzumab With Chop for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I/Ii Results

The Elevation of Cardio-Ankle Vascular Index in a Patient With Malignant Lymphoma Treated With a Combination Therapy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone

Fourteen-Day Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop-14): Use It Right or Do Not Use It at All